Snowball logo
logo
4172

InnoPharmax Inc.

4172 TWO
NT$11.30NT$0.00  (0%)
💡 Click on a row in the table to make it appear on the graph
📊 Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025
Revenue
Total revenue
48.0629.1346.0732.368.99
COGS
40.6529.5128.6211.5359.16
Gross Profit
7.414(0.377)17.4620.769.831
Operating Expenses & Income
Operating Income
(74.37)(93.33)(64.84)(95.98)(171.8)
Total Operating Expenses
81.7992.9582.3110.7240.7
R&D Expenses
60.271.9459.3389.22155.2
Selling General & Admin Expenses
15.915.6917.1717.2926.36
Earnings from Continuing Operations
Interest Expense
(0.398)(0.257)(0.368)(0.307)(0.383)
Interest Income
1.010.9831.6431.9162.837
Income Tax Expense
---2.324-
Net Income
Net Income
(92.97)(103.2)(70.83)(99.29)(184.4)
Supplemental
EBIT
(79.25)(97.11)(61.16)(96.66)-
EBITDA
(69.77)(88.74)(53.92)(90.05)-
In millions of TWD, except % and values per 1 share